Ursodeoxycholic acid and taurine as therapy for cholestatic liver disease
Mary F. Chan, John R. Lake – 1 June 1991 – Relatively hydrophobic bile acids have been shown to produce some hepatotoxicity, whereas treatment with a more hydrophilic bile acid, ursodeoxycholic acid, has improved liver function indices in patients with certain chronic liver diseases. Taurine‐conjugated bile acids are more hydrophilic than glycine‐conjugated bile acids, and thus, taurine administration has also been suggested for the treatment of chronic hepatitis.